Exchanges
BSE, NSE
Industry
Pesticides & Agrochemicals
Issue
Book building

Advance Agrolife IPO

₹108.30

+8.30% on listing

Listing-day close · NSE · 8 Oct 2025 · issue price ₹100

Advance Agrolife’s ₹193 crore IPO was priced at ₹100 a share. It listed on the NSE on 8 Oct 2025 and closed its first day at ₹108.30, up 8.30% on the issue price.

Timeline

  1. Opens
  2. Closes
  3. Allotment
  4. Refunds
  5. Shares in demat
  6. Listing

Issue details

Issue size
₹193 Cr
Fresh issue
₹193 Cr
Offer for sale
—
Lot size
150 shares
Minimum investment
₹15,000
Face value
₹10
Registrar
Kfin Technologies

Subscription

Advance Agrolife IPO subscription by investor category
CategoryShares offeredTimes subscribed
Total—39.68×

Overall, from the basis of allotment.

Financials and valuation

Market cap (post-issue)
₹643 Cr
P/E (post-issue)
25.1
EPS (post-issue)
₹3.99
Price to book
6.0
ROE
25.42%
ROCE
27.02%
Debt to equity
0.80
EBITDA margin
9.61%
PAT margin
5.10%
Promoter holding
99.84% → 69.89%

Financials as of 31 Mar 2025, from the offer documents.

Listing

Listing date
8 Oct 2025
Issue price
₹100
Open
₹114.00
High
₹114.50
Low
₹108.30
Close
₹108.30

Listing day on the NSE. The close was +8.30% on the issue price.

ADVANCE AGROLIFE share price today

FAQs

When did the Advance Agrolife IPO open and close?

It opened on 30 Sep 2025 and closed on 3 Oct 2025.

What was the Advance Agrolife IPO price?

The price band was ₹95–100 a share. The final issue price was ₹100.

What is the lot size and minimum investment?

One lot is 150 shares, ₹15,000 at ₹100 a share. Retail investors apply in whole lots.

How much did Advance Agrolife raise?

₹193 crore: ₹193 crore of new shares.

How many times was the Advance Agrolife IPO subscribed?

39.68 times overall.

How did Advance Agrolife list?

It listed on the NSE on 8 Oct 2025 at ₹114.00 and closed the day at ₹108.30, up 8.30% on the ₹100 issue price.

Who is the registrar of the Advance Agrolife IPO?

Kfin Technologies handles the allotment, refunds and credit of shares.

For information only. Not investment advice or a research report.

Full disclaimer

See how an IPO fits your plan

Armor checks every holding against your goals, risk and timeline.

Get the app